Results 81 to 90 of about 9,923 (187)
Cooling down for going up: Could selective ‘brain chilling’ mitigate high‐altitude illness?
Experimental Physiology, EarlyView.
Adnan Haq, Damian M. Bailey
wiley +1 more source
Pulmonary Circulation, Volume 16, Issue 2, June 2026.ABSTRACT Pulmonary arterial hypertension (PAH) in India is a substantial yet under‐recognized contributor to cardiovascular morbidity and mortality. Its progressive course, nonspecific early manifestations, and heterogeneous aetiologies often lead to delayed diagnosis and fragmented care.
Prashant Bobhate +16 more
wiley +1 more source
Effect of tadalafil on blood glucose.
, 2016 Effect of tadalafil on blood glucose.
LongFei Jia (3150060) +7 more
core +1 more source
Journal of Clinical and Diagnostic ResearchIntroduction: Urethral stricture recurrence following Direct Vision Internal Urethrotomy (DVIU) remains a significant challenge. Phosphodiesterase type-5 inhibitors (PDE5-Is), such as tadalafil, have been proposed to reduce fibrosis and stricture ...
Shyam Sundar Sarkar +2 more
doaj +1 more source
Effect of tadalafil on body weight.
, 2016 Effect of tadalafil on body weight.
LongFei Jia (3150060) +7 more
core +1 more source
Tadalafil in the treatment of erectile dysfunction
, 2008 Robert M Coward, Culley C CarsonDivision of Urologic Surgery, University of North Carolina, Chapel Hill, NC, USAAbstract: The treatment for erectile dysfunction (ED) was revolutionized with the development of phosphodiesterase type 5 (PDE5) inhibitors ...
Robert M Coward, Culley C Carson
core
Time course of the interaction between tadalafil and nitrates
, 2003 ObjectivesThis study was designed to determine the time course of nitrate interaction with tadalafil, a phosphodiesterase 5 (PDE5) inhibitor with a half-life (t1/2) of 17.5 h.BackgroundThe PDE5 inhibitors augment the blood pressure (BP)-lowering effects ...
Hutter, Adolph M +5 more
core +1 more source
Effect of tadalafil on A1C and Triglyceride.
, 2016 Effect of tadalafil on A1C and Triglyceride.
LongFei Jia (3150060) +7 more
core +1 more source
, 2017 Introduction：To evaluate the efficacy and safety of once daily phosphodiesterase type 5 inhibitor(PDE5i) tadalafil as an add-on treatment for men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia（BPH/LUTS）refractory to an alpha
Arai, Gaku +3 more
core
, 2018 Sang-In Park,1,* Su-Hak Heo,2,3,* Gihwan Kim,2 Seokhoon Chang,2 Keon-Hyoung Song,3 Min-Gul Kim,4 Eun-Heui Jin,5 JaeWoo Kim,5 SeungHwan Lee,1 Jang Hee Hong5,6 1Department of Clinical Pharmacology and Therapeutics, Seoul National University College of ...
Lee S +9 more
core